Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer

BACKGROUND: Approximately 20% to 50% of women diagnosed with hormone receptor–positive breast cancer discontinue endocrine therapy early; most reports come from automated pharmacy data or small self-report evaluations. We conducted a larger self-report evaluation of endocrine therapy discontinuation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aiello Bowles, Erin J., Boudreau, Denise M., Chubak, Jessica, Yu, Onchee, Fujii, Monica, Chestnut, Janet, Buist, Diana S.M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Health Care Delivery
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3500489/
https://ncbi.nlm.nih.gov/pubmed/23598850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2012.000543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados